DYRK3 and glioblastoma: Considering the previous report that DYRK3 regulates mTORC1 signaling through the modulation dynamin-related protein 1 (DRP-1) under radiation stress, consequently promoting glioblastoma progression (3), it could be hypothesized that DYRK3 also has an oncogenic feature in other types of cancer, including melanoma skin cancer.